Comparison of intranasal ketamine and intravenous ketorolac in reducing non-traumatic acute headache
Phase 2
Recruiting
- Conditions
- Patients with acute non-traumatic headaches.Other headache syndromes
- Registration Number
- IRCT20180108038276N3
- Lead Sponsor
- Kermanshah University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 72
Inclusion Criteria
All patients with complaints of non-traumatic acute headache
patients with aged of 18 to 50 years old
Patients with a variety of headaches including tension and cluster migraine headaches
Exclusion Criteria
Subjects who have contraindications to the use of ketorolac and vitamin drugs
Patients with focal neurological disorder
Pregnant and weaning women
Patients with headache with impaired consciousness level
Patients with Comorbidity Headaches (Liver and Kidney Failure and Immune Deficiency)
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Pain score of patients with acute non-traumatic headache with visual analogue scale. Timepoint: Pain will be measured immediately before drug administration, 30 minutes, 1 minute and 2 hours after drug administration. Method of measurement: Visual Analog Scale.
- Secondary Outcome Measures
Name Time Method